You just read:

VeroScience Continues to Explore Clinical Benefits of Circadian Neuroendocrine Resetting Therapy® with Six Papers Presented at 2016 American Diabetes Association Scientific Sessions June 10-14

News provided by

VeroScience

Jun 11, 2016, 07:55 ET